CEO's On the Move
Gujarat Themis Biosyn Limited Announces Resignation of Tapas B. Guhathakurata as Chief Executive Officer
Gujarat Themis Biosyn Limited
:Bombay Stock Exchange) Gujarat Themis Biosyn Limited's Board of Directors at its meeting held on December 12, 2017, noted the resignation of Mr. Tapas B. Guhathakurata, as a Chief Executive Officer (CEO) of the company, effective from 12 December, 2017.
Upcoming Board Meetings
December 14, 2017
Sennen Potash Corporation, Board Meeting, Dec 14, 2017.
Sennen Potash Corporation Key Board Members
John Wood Group PLC Appoints Martin Mcintyre as Company Secretary, Replacing William Setter, Effective December 18, 2017
John Wood Group PLC announced that William Setter will step down from his role as Company Secretary with effect from 18 December 2017. He will continue in his role of Group Financial Controller. Martin McIntyre, Group General Counsel, will be appointed as Company Secretary of John Wood Group PLC with effect from 18 December 2017.
Frank Brophy Retires from the Board of Empyrean Energy Plc, Effective December 31, 2017
Empyrean Energy Plc. announced the retirement of Frank Brophy from the Board of the company, effective December 31, 2017.
Bovis Homes Group PLC Announces Board Changes, Effective May 23, 2018
The Board of Bovis Homes Group PLC announced that Alastair Lyons, Deputy Chairman and Senior Independent Director, will retire from the Board at the company's AGM on May 23, 2018, having completed nine years as a non-executive director since the date of his first election. Ralph Findlay, non-executive director, will be appointed to the position of Senior Independent Director with effect from that date.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Top Compensated Executives at GTB:IN
|Chief Executive Officer|
|Chief Financial Officer|
|Compensation as of Fiscal Year 2017. All Compensation is in USD.|
Average Compensation in the Pharmaceuticals Industry